The Traderszone Network

Published in TZ Latest News 30 September, 2015 by The TZ Newswire Staff

Wall Street Comes to Valeant Pharmaceuticals’ Aid

A ‘buy’ rating and $290 price target from one Wall Street firm sends Valeant higher by as much as 12% in midday trading on Wednesday.